Moreover, LY294002 treatment enhanced B-CLL apoptosis induced by Fludarabine (DNA synthesis inhibitor) or Dexamethasone (corticosteroid; Barragan et al., 2002), identifying the PI3K pathway as a good candidate for combination drug therapy. The gene discussed is PIK3CD; the disease is B-cell chronic lymphocytic leukemia.